Jennifer Ficenec: What Happens to Blood Products After Hospitals Say No?
Jennifer Ficenec, Executive Vice President at Blood Centers of America, shared on LinkedIn:
”The Upcycling Mindset: What Happens to Blood Products After Hospitals Say No?
Blood and – any of its components – has a limited shelf lifeΒ during which it is safe for transfusion.
What happens when it is no longer safe for transfusion?
We can repurpose blood and its components to be used in:
– research
– manufacturing
– lab training.
What does it mean? Researchers need live cells and blood-based components as controls or for their experiments.
Sometime we need to test the response of real human cells to new innovations such as chemical compounds, medical devise, or the plastic that is used to handle blood.
Another use is for the training of students and lab personnel on how to handle blood, and its components is essential.
At BCA, we are committed to finding “ππͺπ§π¦” π’π―π₯ “π±πΆπ³π±π°π΄π¦” to those blood and blood-based components we collected from donors to give more use to research and scientific manufacturing community, not just those who need blood or its components directly.
Yes collected blood is used in transfusions by patients who suffered accidents but there are also those who suffer from immune diseases, cancer and other conditions where the blood or blood-based components can be used to treat or research treatments.
Learn more about upcycled products, including LRS chambers that are available for purchase.
Follow us for more on cell therapy innovation and our commitment to patients.”
Stay updated on the emerging with Hemostasis Today.
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care
-
Jun 24, 2026, 07:46Wolfgang Miesbach: WFH’s First AAV Gene Therapy Chapter Marks a New Era in Hemophilia Care
-
Jun 24, 2026, 06:42Deepthi Krishna: World Blood Donor Day 2026 Celebrations at Rela Hospital
-
Jun 24, 2026, 03:36Ana Pedrero Gil: A New Approach to Post-Tonsillectomy Hemorrhage
-
Jun 24, 2026, 02:59Melissa Hollo: Making Early Anemia Detection the Standard of Care
-
Jun 24, 2026, 02:51Bruno Pougault: The Thin Line Between Bleeding and Clotting